GOVONI, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 20.719
EU - Europa 14.759
AS - Asia 5.925
SA - Sud America 251
AF - Africa 130
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 12
Totale 41.832
Nazione #
US - Stati Uniti d'America 20.590
IT - Italia 8.901
CN - Cina 2.674
SG - Singapore 1.699
UA - Ucraina 1.679
DE - Germania 1.143
TR - Turchia 953
GB - Regno Unito 819
FR - Francia 601
SE - Svezia 469
FI - Finlandia 427
ID - Indonesia 241
BR - Brasile 173
NL - Olanda 173
PL - Polonia 105
BE - Belgio 94
EG - Egitto 90
CA - Canada 86
IN - India 68
ES - Italia 56
RU - Federazione Russa 55
CH - Svizzera 50
VN - Vietnam 47
HK - Hong Kong 41
JP - Giappone 41
AU - Australia 33
IR - Iran 31
MX - Messico 31
RO - Romania 30
AT - Austria 29
KR - Corea 25
AR - Argentina 22
LT - Lituania 22
CZ - Repubblica Ceca 21
IE - Irlanda 20
CL - Cile 16
PK - Pakistan 14
SA - Arabia Saudita 13
TW - Taiwan 13
ZA - Sudafrica 13
BD - Bangladesh 11
CO - Colombia 9
IQ - Iraq 9
MY - Malesia 9
PT - Portogallo 9
EC - Ecuador 8
EU - Europa 8
GR - Grecia 8
BO - Bolivia 7
DK - Danimarca 7
NO - Norvegia 7
VE - Venezuela 7
BG - Bulgaria 6
MA - Marocco 6
PE - Perù 6
DZ - Algeria 5
JO - Giordania 5
MD - Moldavia 5
QA - Qatar 5
RS - Serbia 5
IL - Israele 4
NG - Nigeria 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
CU - Cuba 3
CY - Cipro 3
HR - Croazia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PA - Panama 3
PY - Paraguay 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AP - ???statistics.table.value.countryCode.AP??? 2
AZ - Azerbaigian 2
CR - Costa Rica 2
HN - Honduras 2
KZ - Kazakistan 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TG - Togo 2
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
SI - Slovenia 1
Totale 41.832
Città #
Fairfield 2.107
Woodbridge 1.926
Jacksonville 1.674
Chandler 1.620
Santa Clara 1.531
Houston 1.232
Ashburn 1.178
Ann Arbor 1.097
Singapore 1.075
Wilmington 843
Seattle 802
Cambridge 700
Izmir 605
Rome 594
Nanjing 563
Milan 498
Beijing 475
Princeton 424
Cornaredo 244
Ferrara 238
Shanghai 236
Jakarta 222
Boardman 218
San Diego 209
Nanchang 177
Dearborn 175
Bologna 149
Shenyang 145
Los Angeles 144
New York 142
Bremen 127
Naples 123
Hebei 121
Addison 114
San Mateo 101
Jiaxing 99
Helsinki 96
Changsha 94
Redwood City 90
Tianjin 85
Brussels 84
Falkenstein 80
Warsaw 78
Verona 75
Palermo 71
Falls Church 70
Jinan 70
London 69
Padova 68
Norwalk 62
Cagliari 61
Florence 61
Bari 58
Mountain View 57
Munich 54
Alexandria 49
Kunming 48
Napoli 48
Ningbo 47
Dong Ket 43
Philadelphia 43
Guangzhou 41
Toronto 41
Cogne 40
Nuremberg 39
Turin 39
Zhengzhou 38
Frankfurt am Main 37
Auburn Hills 36
Genoa 36
Hong Kong 36
Des Moines 35
Haikou 35
Orange 35
Modena 34
Parma 33
Washington 33
Cairo 30
Pisa 30
Brescia 27
Ottawa 27
Trieste 26
Catania 25
Redmond 25
Taizhou 24
Chicago 23
Tappahannock 23
Council Bluffs 22
Pescara 22
Lanzhou 20
Lappeenranta 19
Torino 19
Vicenza 19
Genova 18
Madrid 18
Reggio Emilia 18
Hangzhou 17
Imola 17
Indiana 17
Leawood 16
Totale 24.679
Nome #
L’OSTEOARTROSI EROSIVA O INFIAMMATORIA DELLA MANO (MALATTIA DI CRAIN). 3.707
POLIENTESOPATIA IPEROSTOSANTE DISMETABOLICA 985
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 954
La iperostosi scheletrica idiopatica diffusa (DISH) [Diffuse Idipathic Skeletal Hyperostosis (DISH)] 939
L’imaging nel neuro-LES 433
Determinazione della VES con metodo tradizionale di Westergren e Test 1 e comparazione dei valori di DAS28 e 44 in una coorte di pazienti affetti da artrite reumatoide 383
Stenosi del canale lombare nella poliartropatia iperostosante dismetabolica 272
CASI CLINICI IN REUMATOLOGIA. DALL’IMMAGINE ALLA DIAGNOSI 252
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 208
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 198
Colon involvement in systemic sclerosis: Clinical-radiological correlations 189
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 182
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 164
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 163
La CEFALEA NEL LUPUS ERITEMATOSO SISTEMICO 160
L'osteonecrosi asettica in corso di lupus eritematoso sistemico: contributo casistico. 159
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 156
2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus 156
Bronchial hyperreactivity in systemic sclerosis patients: Influence of associated Sjogren's syndrome 155
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations 152
LA TIPIZZAZIONE LINFOCITARIA IN REUMATOLOGIA 151
A 49-year-old woman with dyspnoea, palpitations and syncope 151
"Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome": Comment on the article by Zhao et al 148
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: Analysis of a large monocentric cohort with a long-term follow-up 148
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 148
Iperuricemie e gotta classificazione, diagnosi e terapia 145
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 145
L’artrite reumatoide ad esordio senile. 143
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 141
Lupus Eritematoso Sistemico 138
Prevalenza degli anticorpi anti-citrullina (CCP) nell’artrite reumatoide (A.R.): confronto con pazienti affetti da malattia di Still dell’Adulto. Studio preliminare 138
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 138
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study 137
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 137
The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate 137
18FDG-PET and large vessel vasculitis: preliminary data on 25 patients 137
The role of nuclear medicine in the evaluation of neuropsychiatric systemic lupus erythematosus: comment on the article by Sibbitt et al 137
RM, RM di perfusione e Spect del flusso cerebrale nella valutazione del NeuroLes 135
HLA-G may predict the disease course in patients with early rheumatoid arthritis. 134
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 134
Osservazioni sull'anemia in corso di artropatia psoriasica. 133
Connettivite non classificabile e tiroidite autoimmune 133
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 132
Il neuroimaging funzionale nella valutazione del coinvolgimento neurologico in corso di lupus eritematoso sistemico. Risultati preliminari [The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results] 132
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 131
Adult onset Still’s disease 130
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 130
SAPHO syndrome and infections 129
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 129
Combination treatment with etanercept and an intensive SPA rehabilitation program in active ankylosing spondylitis 128
CLINIMETRIA DELLE VASCULITI. ASPETTI CLINICI E NOSOGRAFICI 128
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus 128
Mielite dorsale, sindrome di Sneddon e pervietà del foramen ovale in paziente con lupus-like sindrome ed uveiti recidivanti 127
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 127
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 125
Body weight, gender and response to TNF-  blockers in axial spondyloarthritis 125
Antibodies to retroviral proteins in Sjögren's syndrome 124
Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy 124
Semeiotica della caviglia 124
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 123
Central nervous system involvement in Sjögren's syndrome: Unusual, but not unremarkable-clinical, serological characteristics and outcomes in a large cohort of Italian patients 123
Whipple Disease: Unusual Presentation of a Protean and Sometimes Confusing Disease 122
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 122
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 122
Neurological involvement in primary Sjogren's syndrome: Clinical and instrumental evaluation in a cohort of Italian patients 122
Humeral head osteonecrosis caused by electrical injury: A case report 122
null 121
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 121
Dysfunctional inflammasome in Schnitzler's syndrome 121
Development and first validation of a disease activity score for gout 120
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 120
The Evolution of Adult-Onset Still Disease: An Observational and Comparative Study in a Cohort of 76 Italian Patients 119
Seasonal variation in the onset of acute microcrystalline arthritis 118
Rehabilitation treatment strategies in ankylosing spondylitis. 118
Sternocostoclavicular hyperostosis and the impact of diagnostic delay: comment on the article by Van der Kloot et al. 118
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 118
Bile acid malabsorption in progressive systemic sclerosis 117
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 117
The role of adenosine receptors in rheumatoid arthritis. 115
OSTEOARTROSI E ALTRE FORME DEGENERATIVE 114
Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation. 113
Il ginocchio nella polientesopatia iprostosante dismetabolica: studio xeroradiografico 113
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials 113
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 113
null 112
Investigation of Chlamydia pneumonite and Mycoplasma spp. In clinical specimens from patients with arhritis 112
Italian Society of Rheumatology recommendations for the management of gout 112
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 112
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 112
How I treat patients with adult onset Still's disease in clinical practice 112
null 111
Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature 111
Il quadro radiologico della mano e del piede nel lupus Eritematoso Sistemico èRadiographic findings of the hand and foot in patients with systemic lupus erythematosus] 111
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 110
Meningioma and systemic lupus erythematosus: a matter of pure coincidence ? 110
Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides 110
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 110
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 110
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 110
Overlap fra neuro-LES e sindromi demielinizzanti 109
Totale 19.967
Categoria #
all - tutte 198.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.331
Totale 215.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.012 0 0 0 0 0 0 0 0 550 792 423 247
2020/20215.471 537 534 324 561 316 519 200 523 183 608 732 434
2021/20224.450 207 543 320 248 169 194 196 280 234 369 341 1.349
2022/20234.659 468 269 202 504 656 602 241 426 576 123 359 233
2023/20243.315 277 327 166 133 200 331 162 288 146 229 193 863
2024/20256.392 474 444 973 592 1.445 1.150 349 681 284 0 0 0
Totale 42.718